Universal Ibogaine Engages The Conscious Fund for Corporate Advisory Services Pharmaceutical Investing
FDA Approves Labeling Update for Abbott's HeartMate 3 Heart Pump for use in Pediatric Patients Medical Device Investing
Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data Biotech Investing
FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA® Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic Esophageal and Gastroesophageal Junction Cancer Pharmaceutical Investing
Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Biotech Investing
Algernon CEO and CSO to Discuss COVID-19 Interim Data Results Featured on BioPub Webcast Hosted by Dr. KSS MD PhD Biotech Investing
Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform Medical Device Investing
Bristol Myers Squibb Strengthens its Commitment to the Environment with New Corporate Goals Biotech Investing
KEYTRUDA® Plus LENVIMA® Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective Response Rate Versus Chemotherapy in Patients With Advanced... Pharmaceutical Investing
